{"filings":[{"id":1480286,"accession_number":"0001213900-26-075636","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-07-06T22:09:45+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum Cyber appoints Peter O'Rourke as President of Quantum Drones and Louis Buffalino as director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Peter O'Rourke appointed President of Quantum Drones, effective July 1, 2026; 12-month initial term with automatic six-month renewals.","O'Rourke receives monthly base salary of $20,833.33 (reduced to $16,666.67 for remainder of 2026) and options for 112,859 shares at $1.45.","Louis Buffalino appointed to Board, effective July 1, 2026, filling vacancy; serves on Audit, Compensation, and Nominating committees.","Buffalino qualifies as independent director under Nasdaq listing standards."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1387682,"accession_number":"0001213900-26-074219","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-07-01T20:05:20+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Quantum Cyber signs definitive agreements to acquire Bridgeport manufacturing facility for $3.2M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Subsidiary Quantum Drones Corp. to acquire real property and installed equipment at 38 Union Ave, Bridgeport, CT for $3.2M aggregate consideration.","Facility is approx. 50,000 sq ft on 1.09 acres with direct I-95 access; includes metal-forming and machining assets.","Acquisition advances Quantum Cyber's strategic transition from IP licensing to vertically integrated domestic defense manufacturing.","Also entered Amendment No. 2 to IP License Agreement with BP United, replacing $1M cost reimbursement with a one-time $1M cash payment for technical assistance.","Closing subject to customary conditions; follows June 8, 2026 LOI and supports Trump Administration's drone dominance executive order."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1306087,"accession_number":"0001213900-26-072688","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-06-26T21:00:15+00:00","items":["4.01","9.01"],"status":"ready","headline":"Quantum Cyber dismisses Reliant CPA PC, appoints Haskell & White; Reliant flagged going concern doubts","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed Reliant CPA PC effective June 22, 2026; Haskell & White LLP appointed as independent auditor for FY 2026.","Reliant's reports for FY 2024 and 2025 included a going concern emphasis paragraph citing significant operating losses.","No disagreements or reportable events occurred during Reliant's tenure from January 2023 to dismissal.","Audit Committee approved both dismissal and appointment on June 22, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1056478,"accession_number":"0001213900-26-068778","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-06-15T20:06:01+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Quantum Cyber signs exclusive quantum antenna license with Project LightShift for $1M cash + $5M stock","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Consideration: $1M cash plus $5M in restricted shares, vesting over eight quarters with six-month lock-up.","Exclusive worldwide license for quantum photonic array technology for defense drone applications.","Prototype milestone: LightShift to deliver prototype by Dec 31, 2026; company has 120-day right of first negotiation for commercialization.","Company can terminate license if prototype not delivered by March 31, 2027; unvested shares clawed back, vested shares repurchased at $0.001/share.","Voting agreement: LightShift agrees to vote all shares from the license in favor of board-recommended proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":888204,"accession_number":"0001213900-26-065802","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-06-05T20:05:27+00:00","items":["1.02"],"status":"ready","headline":"Quantum Cyber terminates at-the-market equity facility with Maxim Group; had raised ~$4.4M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Terminated ATM sales agreement with Maxim Group LLC effective June 7, 2026.","Prior to termination, sold 3,280,927 ordinary shares for net proceeds of ~$4,388,515.","No termination penalties were incurred by the company.","Company traded on Nasdaq under ticker QUCY; no replacement facility announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":816196,"accession_number":"0001213900-26-064465","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-06-03T12:44:08+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Quantum Cyber amends IP license with BP United; retains $5M cash for manufacturing ramp-up","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment No. 1 modifies the May 12, 2026 IP License Agreement with BP United Inc.","BP United will now provide manufacturing and consulting services instead of an exclusive supply agreement.","$5M cash payment originally due to BP United is retained by Quantum Cyber for manufacturing ramp-up.","Consideration Shares vest in four equal installments through September 30, 2027.","All references to the Supply Agreement have been removed from the original agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":721800,"accession_number":"0001213900-26-062109","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-05-28T20:05:36+00:00","items":["8.01"],"status":"ready","headline":"Quantum Cyber regains Nasdaq minimum bid price compliance; deficiency notice closed","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter on May 28, 2026 confirming bid price >=$1.00 for 10 consecutive business days (May 13-27, 2026).","Previously notified of deficiency on March 20, 2026 for failing minimum bid price requirement.","Company now compliant with Nasdaq Listing Rule 5550(a)(2); matter closed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":667677,"accession_number":"0001213900-26-061021","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-05-26T20:09:50+00:00","items":["8.01","9.01"],"status":"ready","headline":"Quantum Cyber pivots from biotech to defense AI and quantum autonomous systems","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Changed name from Mainz Biomed to Quantum Cyber N.V.; ticker changed to QUCY.","Acquired IP license from BP United Inc. for autonomous systems and drone technologies.","Targeting U.S. DoD and allied defense markets with products QC-Swarm, QC-Nav, QC-Sense, QC-Shield.","Holds six pending U.S. patent applications covering drone-related innovations.","Plans heavy R&D investment to integrate AI and quantum computing into autonomous platforms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":499048,"accession_number":"0001213900-26-058427","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-05-18T20:05:31+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Quantum Cyber licenses drone/cyber IP from BP United for $5M cash and 20M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exclusive, perpetual, worldwide license to BP United's IP (patents, trademarks, know-how) for drones and cyber applications.","Consideration: $5M cash plus 20M restricted shares (6-month lock-up, 5% volume restriction) at prior closing price.","Conditions precedent: satisfactory IP due diligence, USPTO corrective filings, and execution of securities purchase agreement; Company may terminate if unmet within 90 days.","Entered Advisory Agreement with Alexander Gurevich: 5M restricted shares at $0.40 for strategic advisory (12-month term).","Appointed Peter O'Rourke as director effective May 13, 2026; he has government/defense background."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96472,"accession_number":"0001213900-26-053865","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Quantum Cyber increases equity distribution capacity to $100M; CFO Caragol moves to consulting role","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Equity distribution agreement amended; offering amount increased from $10M to $100M.","CFO William Caragol enters consulting agreement, effective April 22, 2026, with $20,000 monthly retainer.","Caragol commits up to 50% of professional time; term through August 31, 2026, with possible monthly extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96471,"accession_number":"0001213900-26-048635","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["1.01","3.02","5.01","5.02","5.03","5.07","9.01"],"status":"ready","headline":"Quantum Cyber N.V. issues $6M preferred shares; David Lazar gains >95% voting control and Co-CEO resigns","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Second closing on Apr 22, 2026: issued Series D/E preferred convertible into up to 225M ordinary shares each, representing >90% fully diluted shares.","David Lazar becomes controlling shareholder with >95% voting rights; four directors and Co-CEO Guido Baechler resigned; David Natan and Avraham Ben-Tzvi appointed.","Name changed from Mainz Biomed N.V. to Quantum Cyber N.V.; authorized ordinary shares increased from 45M to 900M, preferred from 5M to 100M.","All 11 proposals approved at Apr 22 Extraordinary General Meeting, including ratification of board appointments and share issuance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96470,"accession_number":"0001213900-26-044125","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["1.01","8.01"],"status":"ready","headline":"Mainz Biomed sells next-gen CRC screening IP for $1.25M, updates Nasdaq equity compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered asset purchase agreement to sell Next Gen IP for $1.25M; closing by April 23, 2026.","Proceeds to be used for settlement of outstanding liabilities and general corporate purposes.","Continues development of pancreatic cancer detection product and explores post-quantum cybersecurity.","Believes stockholders' equity exceeds $2.5M after receiving $6M total from preferred share sale (Feb & March 2026).","Previously wound down ColoAlert product and next-gen colorectal cancer screening development in Feb 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110395,"accession_number":"0001213900-26-034103","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-03-25T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Mainz Biomed receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Sep 16, 2026","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Mainz Biomed on Mar 20, 2026 that its share price closed below $1.00 for 30 consecutive business days through Mar 19, 2026.","Company has 180 calendar days, until Sep 16, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.","If not cured by Sep 16, 2026, Mainz may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.","There can be no assurance of regaining compliance or avoiding delisting; the letter has no immediate impact on trading."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110394,"accession_number":"0001213900-26-028672","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Quantum Cyber pre-funded $3M by David Lazar; targets acquisitions in quantum & cyber defense","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["David Lazar pre-funded $3M second tranche; total investment now $6M.","Closing of tranche subject to stockholder approval and customary conditions.","Company aligns strategy with Trump Administration's National Cybersecurity Strategy released March 10, 2026.","Evaluating acquisition pipeline in quantum computing, post-quantum cryptography, zero-trust architecture.","No definitive acquisition agreements reached; management optimistic about pipeline quality."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110393,"accession_number":"0001213900-26-025940","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-03-11T23:59:59+00:00","items":["5.02","7.01","8.01","9.01"],"status":"ready","headline":"Mainz Biomed appoints cyber security veteran Robert Liscouski as Chairman; ticker changes to QUCY","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Robert P. Liscouski appointed Chairman effective March 11, 2026; election to be ratified at April 2026 EGM.","Nasdaq ticker symbol changes from MYNZ to QUCY effective March 12, 2026; company plans name change to Quantum Cyber.","Liscouski is former DHS Assistant Secretary for Infrastructure Protection and co-founder/CEO of Quantum Computing Inc. (QUBT).","Company winding down German subsidiary, focusing on U.S. pancreatic cancer screening, evaluating sale of colorectal cancer assets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110392,"accession_number":"0001213900-26-016890","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-02-17T23:59:59+00:00","items":["1.01","5.02","3.02","3.03","5.03","8.01","9.01"],"status":"ready","headline":"Mainz Biomed secures $6M private placement, names David Lazar Chairman; pivots to pancreatic cancer","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["First tranche of $3M closed Feb 13; second $3M expected after shareholder approval by April 15, 2026.","Preferred shares convertible into up to 95%+ of fully diluted shares; Lazar appointed Chairman and gets board nomination rights.","Company to focus on U.S. pancreatic cancer detection, evaluate sale of colorectal assets, wind down German sub.","Settlement agreements with officers/directors require ~$1.9M aggregate payments upon final closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110391,"accession_number":"0001213900-26-014378","cik":1874252,"company_name":"Quantum Cyber N.V.","ticker":"QUCY","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Mainz Biomed raises $2.15M via ATM equity offering; fully utilizes prospectus supplement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 1,735,194 ordinary shares at prevailing market prices for gross proceeds of $2,152,822.40.","Prospectus supplement filed Dec 29, 2025, now fully utilized.","Overall ATM capacity of up to $10M remains available for future sales.","Sales agent Maxim Group LLC; net proceeds after commissions not disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":43983507.849829346,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}